Shawn Aspden, CFA, is a Principal in Investment Banking at Bloom Burton, specializing in mergers & acquisitions, equity and debt capital raising, and capital markets strategy for public and private healthcare issuers. With more than 25 years of experience, Shawn has advised founder‑owned companies, public corporations and private equity sponsors on strategic transactions in pharmaceutical and healthcare services. His recent mandates include advising on multi‑party competitive sale processes, structuring minority equity investments, and raising senior and subordinated debt to support expansion initiatives.
Prior to joining Bloom Burton in 2016, Shawn built a significant capital‑markets track record, including serving as Head of North American Institutional Equity Sales at GMP Securities and Head of Institutional Sales at Orion Securities.
Shawn currently serves as Chair of the Board of Grey Wolf Animal Health (TSXV: WOLF) and was previously Chair of the Foundation Board at Greenwood College School. He holds the Chartered Financial Analyst (CFA) designation and an HBA from the Ivey Business School.
Shawn Aspden is a Principal at Bloom Burton, with a primary role in investment banking, advising issuers on capital raises, mergers and acquisitions and capital markets strategy. Shawn has worked alongside healthcare companies for over 25 years and has extensive institutional investor relationships and experience in raising growth capital.
